HomeNRIX • NASDAQ
add
Nurix Therapeutics Inc
Previous close
$12.73
Day range
$12.70 - $13.73
Year range
$4.22 - $18.12
Market cap
757.90M USD
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Feb 2024info | Y/Y change |
---|---|---|
Revenue | 16.58M | 30.74% |
Operating expense | 11.80M | 20.14% |
Net income | -41.52M | -1.93% |
Net profit margin | -250.33 | 22.04% |
Earnings per share | -0.76 | -1.33% |
EBITDA | -43.17M | -4.79% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Feb 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 243.99M | -11.96% |
Total assets | 312.67M | -15.53% |
Total liabilities | 143.93M | 49.76% |
Total equity | 168.75M | — |
Shares outstanding | 49.15M | — |
Price to book | 3.71 | — |
Return on assets | -33.83% | — |
Return on capital | -52.70% | — |
Cash Flow
Net change in cash
(USD) | Feb 2024info | Y/Y change |
---|---|---|
Net income | -41.52M | -1.93% |
Cash from operations | -41.95M | 13.42% |
Cash from investing | 35.51M | 121.02% |
Cash from financing | 1.62M | 9.66% |
Net change in cash | -4.81M | 84.42% |
Free cash flow | -17.97M | 28.51% |
About
Founded
2009
Headquarters
Website
Employees
284